BEAM-Logo-Color and Black-Large-576x375.png
Beam Global to Release Third Quarter 2023 Operating Results, Conference Call Scheduled for November 14, 2023 at 8:30 a.m. ET
07 nov. 2023 11h00 HE | Beam Global
Beam Global Announces Q3 2023 Earnings Call Date and Time
Lightbridge Corporation Logo
Lightbridge Provides Business Update and Announces Third Quarter 2023 Financial Results
30 oct. 2023 16h05 HE | Lightbridge Corporation
Lightbridge Provides Business Update and Announces Third Quarter 2023 Financial Results
Visteon Announces Third Quarter 2023 Results
26 oct. 2023 06h55 HE | Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today reported third quarter 2023 financial results. Highlights include: Sales of $1,014 million,...
BWEN Logo.png
Broadwind Announces Third Quarter 2023 Conference Call And Webcast Date
25 oct. 2023 18h00 HE | Broadwind, Inc.
CICERO, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced that it...
ARCA Logo - JPEG.jpg
ARCA biopharma Announces Third Quarter 2023 Financial Results
18 oct. 2023 16h25 HE | ARCA biopharma, Inc.
ARCA biopharma Announces Third Quarter 2023 Financial Results
Robbins LLP logo white Background.png
AeroVironment, Inc. Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in AeroVironment, Inc. (AVAV) Class Action
11 sept. 2023 17h04 HE | Robbins LLP
SAN DIEGO, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased or otherwise acquired AeroVironment, Inc....
CENTOGENE Reports First Half 2023 Financial Results
07 sept. 2023 17h00 HE | Centogene NV
First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue...
Alvotech Reports Fin
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update
30 août 2023 16h15 HE | Alvotech
Product revenue for the first six months of 2023 increased to $22.7 million, compared to $3.9 million for the same period in 2022Investors, including Teva Pharmaceuticals, subscribed to Alvotech’s...
Alvotech to Report F
Alvotech to Report Financial Results for the First Half of 2023 on August 30, 2023, and Host Business Update Conference Call on August 31, 2023, at 8:00 am ET
22 août 2023 09h15 HE | Alvotech
REYKJAVIK, Iceland, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide,...
AgileThought Reports Second Quarter 2023 Financial Results
14 août 2023 16h22 HE | AgileThought
IRVING, Texas, Aug. 14, 2023 (GLOBE NEWSWIRE) -- AgileThought, Inc. (“AgileThought” or the “Company”) (NASDAQ: AGIL), a global provider of digital transformation services, custom software...